Quiz Summary
0 of 10 Questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
0 of 10 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Categories
- Not categorized 0%
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- Current
- Review
- Answered
- Correct
- Incorrect
-
Question 1 of 10
1. Question
Question 1 of 10
How many recognised ‘hallmarks of cancer’ are there?
-
Question 2 of 10
2. Question
Question 2 of 10
How many DNA mutations are required for a cell to behave as a cancer cell?
-
Question 3 of 10
3. Question
Question 3 of 10
Which of the following statements about telomeres are true?
-
Question 4 of 10
4. Question
Question 4 of 10
What is the process that allows cancer cells to metastasize?
-
Question 5 of 10
5. Question
Question 5 of 10
Which of the following are tumour suppressor proteins?
-
Question 6 of 10
6. Question
Question 6 of 10
Which of the following are ways in which tumour cells can evade the immune system?
-
Question 7 of 10
7. Question
Question 7 of 10
By which mechanism do cancer cells generate energy?
-
Question 8 of 10
8. Question
Question 8 of 10
Match the drug to its target
Sort elements
- Vascular Endothelial Growth Factor Receptor Tyrosine Kinase
- Epithelial Growth Factor Receptor
- BRAF
- Human Epithelial Growth Factor Receptor (HER2)
- Programmed Death Receptor-1
- mTOR
- MEK
-
Sunitinib
-
Cetuximab
-
Dabrafenib
-
Trastuzumab
-
Nivolumab
-
Everolimus
-
Trametinib
-
Question 9 of 10
9. Question
Question 9 of 10
Which subtype of PI3K is commonly mutated in solid tumours?
-
Question 10 of 10
10. Question
Question 10 of 10
Select the correct statement relating to response to different treatment types
Sort elements
- high response rate + short duration of response
- higher response rate + improved duration of response
- low response rate + prolonged duration of response
-
Cytotoxic chemotherapy
-
Targeted treatments
-
Checkpoint inhibitors